Home › Hopkins and Bayer to develop treatments for eye diseases
 

Keywords :   


Hopkins and Bayer to develop treatments for eye diseases

2015-06-16 14:58:01| Chemicals - Topix.net

The Johns Hopkins University has entered into a five-year agreement with Bayer HealthCare to develop drugs to treat diseases of the eye. Under the agreement, researchers at the Wilmer Eye Institute at Johns Hopkins and Bayer will work together to study things such as biomarkers for back-of-the-eye diseases with few available treatments.

Tags: develop eye diseases treatments

Category:Chemicals

Latest from this category

All news
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
20.09New Acrylic Resin for Architectural Coatings Without Fluorosurfactants from EPS
20.09¦nie¿ka Publishes Results for 1H 2024
20.09Sheboygan Paint Company Appoints Fallon Phillip HR Director
20.09RadTech Europe (RTE) Sets Call for Papers
19.09Lubrizol Enhances Dispersant Production Capacity in North America
19.09PPG Announces Two-year Partnership with Foundation for Environmental Education
Chemicals »
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
21.09Atlantic Tropical Weather Outlook
More »